Introduction
This FAQ explains what scleroderma is, why it happens, how it is diagnosed, and what treatment can do to help. It also covers long-term outlook, risk factors, prevention, and a few less common questions people often have after hearing the diagnosis. Scleroderma is not a single disease with one predictable pattern. It is an autoimmune condition that can affect the skin, blood vessels, and internal organs in different ways, so understanding the type of scleroderma matters.
Common Questions About Scleroderma
What is scleroderma? Scleroderma is a chronic autoimmune disease in which the body makes too much collagen, the protein that helps give skin and connective tissue their strength. When collagen builds up excessively, tissues become thickened and stiff. In some people, this process mainly affects the skin. In others, it can involve blood vessels, the digestive tract, lungs, heart, kidneys, or muscles. The term “scleroderma” means “hard skin,” but the condition can be much broader than skin changes alone.
There are two main patterns. Localized scleroderma primarily affects the skin and nearby tissues. Systemic sclerosis, often called systemic scleroderma, can affect internal organs and blood vessels in addition to the skin. Systemic sclerosis is usually the form people worry about when they ask about organ complications.
What causes it? The exact cause is not fully known. Scleroderma appears to develop from a combination of immune system dysfunction, blood vessel injury, and overproduction of collagen. In simple terms, the immune system becomes overactive, small blood vessels are damaged, and the body responds by laying down scar-like tissue. Over time, that fibrosis can interfere with normal tissue function.
Genetics may contribute to susceptibility, but scleroderma is not usually inherited in a straightforward way. Environmental exposures may also play a role in some people, including certain solvents, silica dust, and possibly some viral or other triggers. None of these factors causes scleroderma by itself in most cases; they may help set the stage in someone who is already vulnerable.
What symptoms does it produce? Symptoms vary widely depending on the type and severity of the disease. One of the earliest signs in systemic sclerosis is often Raynaud phenomenon, in which fingers or toes turn white or blue in response to cold or stress because blood vessels narrow too easily. The skin may then become red as blood flow returns. This happens because the small vessels are unusually reactive and damaged.
Skin tightening is another hallmark. The skin can feel firm, thick, or shiny, and joint movement may become limited if the skin around the hands or other areas stiffens. Some people develop swelling before the skin becomes firm. Other common symptoms include joint pain, fatigue, heartburn, trouble swallowing, shortness of breath, dry eyes or mouth, and changes in the hands such as puffy fingers or small calcium deposits under the skin.
When internal organs are involved, symptoms can reflect the affected system. Lung disease may cause cough or reduced exercise tolerance. Digestive involvement can lead to reflux, bloating, constipation, or diarrhea. Kidney involvement is less common but can be serious and may cause sudden high blood pressure. Because the disease can affect different tissues in different ways, symptoms often develop gradually and can be easy to miss at first.
Questions About Diagnosis
How is scleroderma diagnosed? Diagnosis begins with a medical history and physical examination. A clinician looks for skin thickening, Raynaud phenomenon, finger changes, digital ulcers, and signs of organ involvement. Because early symptoms can resemble other conditions, diagnosis often depends on putting several findings together rather than on one single test.
Blood tests can help support the diagnosis. Certain autoantibodies are associated with systemic sclerosis, including antinuclear antibodies and more specific antibodies such as anticentromere, anti-topoisomerase I, and anti-RNA polymerase III. These tests do not diagnose the condition on their own, but they help identify the subtype and may suggest which complications are more likely.
Doctors often order tests to check for organ involvement. Pulmonary function tests can measure lung capacity and gas exchange. Echocardiography can screen for heart strain or pulmonary hypertension. High-resolution CT scans may detect lung scarring. Blood pressure, kidney function, and urine tests may be monitored closely. A nailfold capillaroscopy exam, which looks at tiny blood vessels near the fingernails, can show patterns that are characteristic of systemic sclerosis and support early diagnosis.
Is a biopsy needed? Sometimes, but not always. A skin biopsy may be useful if the diagnosis is unclear, especially in localized forms or unusual cases. In many people, the clinical picture and blood work are enough. Doctors usually prefer the least invasive approach that still gives a clear answer.
Why can diagnosis take time? Early scleroderma may start with vague complaints such as Raynaud phenomenon, hand swelling, or reflux. Skin thickening and other more obvious signs may appear later. Since the disease is uncommon and can mimic other autoimmune or vascular disorders, diagnosis may require evaluation by a rheumatologist, often with input from lung, heart, or gastrointestinal specialists.
Questions About Treatment
Can scleroderma be cured? There is currently no cure that reverses the underlying autoimmune process in every case. Treatment focuses on controlling symptoms, slowing disease progression, and protecting organs. In some forms, especially localized scleroderma, the disease may become inactive over time. In systemic sclerosis, long-term management is often needed.
What medications are used? Treatment depends on which parts of the body are involved. For skin and inflammatory disease, doctors may use medicines that affect the immune system, such as methotrexate, mycophenolate, or other immunomodulating drugs. For Raynaud phenomenon and digital ulcers, calcium channel blockers and other blood vessel-targeting medications may help improve circulation. If the lungs are involved, medications that reduce inflammation and fibrosis may be considered, along with close monitoring.
Acid reflux is commonly treated with proton pump inhibitors or similar medicines to reduce acid damage. Kidney involvement requires urgent specialist care and blood pressure control. In selected cases, especially severe or rapidly progressing disease, more intensive treatments may be used. The exact plan depends on the subtype, organs involved, and overall severity.
What about non-drug treatment? Supportive care is an important part of management. Keeping warm helps reduce Raynaud attacks. Hand and joint exercises can preserve flexibility. Skin moisturizers may ease dryness and cracking. Physical and occupational therapy can help maintain function and adapt daily tasks. If swallowing or reflux is a problem, smaller meals, avoiding late-night eating, and elevating the head of the bed may reduce symptoms. Because lung and heart involvement may be silent early on, regular screening is a key part of treatment rather than an optional add-on.
Does treatment work? Treatment can make a meaningful difference, especially when the disease is recognized early and monitored closely. Some therapies reduce complications, improve quality of life, and slow progression. The response varies, and management often involves adjusting treatment over time. The main goal is not only to treat existing symptoms but also to prevent avoidable organ damage.
Questions About Long-Term Outlook
Is scleroderma life-threatening? It can be, but the risk depends heavily on the type and extent of disease. Localized scleroderma usually does not affect internal organs and is far less likely to threaten life. Systemic sclerosis can be serious when it affects the lungs, heart, kidneys, or gastrointestinal tract. Even then, outcomes vary widely. Some people have mild, slowly changing disease, while others experience faster progression or organ complications.
Does it always get worse? Not necessarily. Scleroderma does not follow one fixed pattern. Some people have symptoms that stabilize after an active early phase. Others have gradual progression over years. A key reason for regular follow-up is that organ involvement may develop later even when skin symptoms seem stable.
What complications are most concerning? Lung disease is one of the major long-term concerns, especially interstitial lung disease and pulmonary arterial hypertension. Both can reduce oxygen delivery and strain the heart. Kidney crisis is less common but can develop suddenly and requires emergency treatment. Severe digestive involvement, heart rhythm problems, and significant skin tightening can also affect health and daily function. The long-term outlook improves when these issues are detected early.
Can people live a normal life? Many people with scleroderma can remain active, work, and manage family responsibilities, especially when the disease is limited or well controlled. The condition may require ongoing monitoring and lifestyle adjustments, but it does not prevent a meaningful life for many patients. The practical burden often comes from symptom management, medical visits, and the unpredictability of flare-ups or progression.
Questions About Prevention or Risk
Can scleroderma be prevented? No proven method can fully prevent it. Because the underlying cause is a mix of immune, vascular, and fibrotic changes, there is no simple preventive strategy. However, people at risk can reduce some aggravating factors and seek care early if symptoms appear.
Who is at higher risk? Scleroderma is more common in women than in men, and it often begins in adulthood, though it can occur at any age. Family history of autoimmune disease may increase susceptibility, but most people with scleroderma do not have a direct relative with the same condition. Environmental exposures such as silica dust and some industrial chemicals have been linked to higher risk in certain studies.
Can lifestyle changes lower the chance of complications? While lifestyle changes do not prevent the disease, they can help protect health once symptoms begin. Avoiding smoking is especially important because tobacco can worsen blood vessel problems and Raynaud symptoms. Protecting the hands and feet from cold, managing reflux triggers, and staying physically active within tolerance may reduce symptom burden. Good dental and skin care also help because dryness, stiffness, and limited hand mobility can create practical problems.
Should people with Raynaud phenomenon be checked? Yes, especially if Raynaud begins in adulthood, becomes severe, or comes with puffy fingers, skin thickening, reflux, or abnormal blood tests. Raynaud can occur on its own, but it can also be an early clue to systemic sclerosis. Evaluation is important when the pattern seems unusual or progressive.
Less Common Questions
Is scleroderma contagious? No. It cannot be spread from person to person.
Is it the same as osteoarthritis or lupus? No. Scleroderma is a separate autoimmune disease. It can overlap with other autoimmune conditions, and some symptoms may resemble lupus, rheumatoid arthritis, or other connective tissue diseases. That is one reason specialized evaluation is often helpful.
Can pregnancy be affected? Pregnancy is possible for many people with scleroderma, but it should be planned carefully with medical guidance. Disease stability, lung and heart function, blood pressure, and medication safety all matter. Some medicines used for scleroderma are not safe during pregnancy and must be reviewed well in advance.
Why do the fingers change so much? The fingers are often affected early because their small blood vessels are sensitive to injury and narrowing. Reduced blood flow can lead to color changes, pain, ulcers, and delayed healing. Over time, fibrosis can tighten the skin and limit finger movement. This combination of vascular and fibrotic changes is one of the most distinctive features of the disease.
Are there different names for different forms? Yes. Limited cutaneous systemic sclerosis usually affects the skin of the hands, arms, face, and lower legs and may have a slower course. Diffuse cutaneous systemic sclerosis tends to involve more widespread skin thickening and has a higher risk of early internal organ involvement. Localized scleroderma, including morphea, affects the skin and sometimes deeper tissues but usually does not involve internal organs in the same way.
Conclusion
Scleroderma is an autoimmune disease marked by abnormal collagen buildup, blood vessel injury, and tissue fibrosis. Its effects range from limited skin changes to serious internal organ involvement, which is why diagnosis and follow-up matter so much. Early recognition of symptoms such as Raynaud phenomenon, skin tightening, reflux, or shortness of breath can lead to earlier testing and treatment. Although there is no cure, many treatments can ease symptoms, slow progression, and reduce complications. With careful monitoring and a coordinated care plan, many people with scleroderma can manage the condition effectively over time.